AVDL vs MTD · rev $169.1M vs P/E 27, rev $1.97B
Avadel Pharmaceuticals PLC (AVDL) versus Mettler-Toledo International Inc (MTD) — a side-by-side from cached financials, not a winner call.
Avadel Pharmaceuticals PLC (AVDL) is a drug manufacturers - specialty & generic company listed on US.
Mettler-Toledo International Inc (MTD) is a diagnostics & research company listed on NYSE.
Latest reported AVDL revenue for 2024-12-31 was $169.1M. Net income was -$48.8M. Revenue was up 504.8% from 2023-12-31 to 2024-12-31. AVDL currently screens at market cap $968.5M.
Latest reported MTD revenue for 2026-06-30 was $1.97B. Net income was $402.4M. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
AVDL currently screens at market cap $968.5M. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
Not investment advice. Open the AVDL and MTD stock pages for the full models.
Not investment advice.